![Eric Rubin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Rubin
Director/Board Member at
NATERA, INC.
Net worth: 598 276 $ as of 30/06/2026
Profile
Dr. Eric H.
Rubin, MD, is an Independent Director at Natera, Inc. He is on the Board of Directors at Natera, Inc. Dr. Rubin was previously employed as an Independent Director by Oncorus, Inc., a Senior VP-Global Clinical Oncology by Merck & Co., Inc., a Member by American Cancer Society, Inc., a Member by National Cancer Institute, and a Director-Investigational Therapeutics Division by Rutgers Cancer Institute of New Jersey.
He received his undergraduate degree from Tulane University (Louisiana) and a doctorate degree from the University of South Florida.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/06/2026 | 2,204 ( 0% ) | 598 276 $ | 30/06/2026 |
Eric Rubin active positions
| Companies | Position | Start |
|---|---|---|
| NATERA, INC. | Director/Board Member | 26/03/2026 |
Former positions of Eric Rubin
| Companies | Position | End |
|---|---|---|
| ONCORUS, INC. | Director/Board Member | 28/07/2023 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2023 |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Corporate Officer/Principal | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
The Cancer Institute of New Jersey
 The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services Operates cancer center | Corporate Officer/Principal | - |
Training of Eric Rubin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
48
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Tulane University (Louisiana)
 Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
American Cancer Society, Inc.
American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Commercial Services |
The Cancer Institute of New Jersey
The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services Operates cancer center | Health Services |
Natera, Inc.
 Natera, Inc. BiotechnologyHealth Technology Engages in development and commercialization of molecular testing and technology services in the fields of women’s, oncology and organ health | Health Technology |
Oncorus, Inc.
 Oncorus, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops next generation immunotherapy platform to treat cancer | Health Technology |
- Stock Market
- Insiders
- Eric Rubin
